Clinical & Experimental Metastasis

Papers
(The TQCC of Clinical & Experimental Metastasis is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Congratulations to Prof. em. Garth L. Nicolson – co-founder of Clinical & Experimental Metastasis107
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics51
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches49
The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma44
Metastatic profiling of HER2-positive breast cancer cell lines in xenograft models28
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption23
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics22
The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria21
LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression21
Oncolytic intralesional therapy for metastatic melanoma19
Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection19
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG19
Preoperative embolization of renal cell carcinoma metastases to the bone prior to stabilization procedures does not result in reduction in intraoperative blood loss19
Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review18
High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions17
Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression17
Axillary nodal staging in breast cancer: what have we learned?17
Cell blebbing novel therapeutic possibilities to counter metastasis16
Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer15
Correction: CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells15
CT-based deep learning model: a novel approach to the preoperative staging in patients with peritoneal metastasis15
Topography and probability diagram of cervical and intra-parotid lymph node metastasis in parotid gland cancer15
Editorial: Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis14
Nectin-4 is frequently expressed in primary salivary gland cancer and corresponding lymph node metastases and represents an important treatment-related biomarker14
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations14
Therapy resistance and metastasis14
Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer14
Fluid shear stress influences invasiveness of HeLa cells through the induction of autophagy13
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis13
Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients’ selection13
Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade13
Current preclinical models of brain metastasis13
Correction: SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells12
Histopathological growth patterns of neuroendocrine tumor liver metastases11
The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study11
Tumor microenvironment dynamics in oral cancer: unveiling the role of inflammatory cytokines in a syngeneic mouse model11
Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro/eortc consensus recommendations11
Efficacy and safety of PARPis combined with an ICIs for advanced or metastatic triple-negative breast cancer: a single-arm meta-analysis11
Etiology and treatment of cancer-related secondary lymphedema11
Targeting PADI2 as a potential therapeutic strategy against metastasis in oral cancer via suppressing EMT-mediated migration and invasion and CCL3/5-induced angiogenesis10
‘Sandwich treatment’ for posterior fossa brain metastases with volume larger than 4cm3: a multicentric retrospective study10
Should EUS-FNA be considered also for the diagnosis of peripheral small pulmonary lesions?10
Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK110
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results10
Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis10
Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics10
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation10
0.14465308189392